Proton-sensing ion channels, GPCRs and calcium signaling regulated by them: implications for cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tumor cells sense acidity via proton-sensing ion channels and G protein-coupled receptors (GPCRs), impacting calcium signaling and cancer progression. Targeting these pathways offers promising anticancer drug development opportunities.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Extracellular acidification is a common hallmark of tumors.
- Tumor cells utilize proton-sensing ion channels and G protein-coupled receptors (GPCRs) to detect and respond to acidic microenvironments.
- This sensing mechanism triggers intracellular signaling, notably calcium signaling, influencing tumor cell behavior.
Purpose Of The Study
- To review the current understanding of proton-sensing ion channels and GPCRs in cancer.
- To highlight the role of calcium signaling, activated by these receptors, in tumor progression.
- To explore the therapeutic potential of targeting these pathways in anticancer drug development.
Main Methods
- Literature review of studies on proton-sensing ion channels and GPCRs.
- Analysis of the impact of associated calcium signaling on tumor characteristics.
- Review of drugs targeting these pathways currently in clinical trials or under development.
Main Results
- Proton-sensing ion channels and GPCRs significantly influence tumor proliferation, migration, invasion, metastasis, drug resistance, and angiogenesis via calcium signaling.
- These receptors and pathways have been largely underexplored as drug targets despite their therapeutic potential.
- Several drugs targeting proton-sensing channels or GPCRs are in clinical trials, showing promise for cancer treatment.
Conclusions
- Proton-sensing ion channels, GPCRs, and their downstream calcium signaling play critical roles in cancer initiation and progression.
- Targeting these pathways represents a promising strategy for novel anticancer drug development.
- Further research and clinical trials are warranted to fully exploit the therapeutic advantages of these targets.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...